Allele loss on short arm of chromosome 17 in breast cancers - PubMed (original) (raw)
Allele loss on short arm of chromosome 17 in breast cancers
J Mackay et al. Lancet. 1988.
Abstract
Tumour and blood leucocyte DNA from a consecutive series of patients with primary breast cancer was probed to detect deletions at six polymorphic loci in tumour tissue. The highest frequency of allele loss (61%) was found with the probe YNZ22, which detects a sequence on the short arm of chromosome 17 (at p13.3). The previously reported loss of alleles at the Harvey ras locus (11p14) in about 20% of breast tumours was confirmed. The putative breast tumour suppressor gene on 17p may be the same as that already noted for colon and lung cancers and it is suggested that deletion of this gene is one of a cumulative series of lesions involving genetic changes in the evolution of breast cancer. The findings identify chromosome 17p as a candidate region for linkage studies in breast cancer families.
Similar articles
- Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.
Coles C, Thompson AM, Elder PA, Cohen BB, Mackenzie IM, Cranston G, Chetty U, Mackay J, Macdonald M, Nakamura Y, et al. Coles C, et al. Lancet. 1990 Sep 29;336(8718):761-3. doi: 10.1016/0140-6736(90)93236-i. Lancet. 1990. PMID: 1976143 - Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas.
Lindblom A, Skoog L, Andersen TI, Rotstein S, Nordenskjöld M, Larsson C. Lindblom A, et al. Hum Genet. 1993 Mar;91(1):6-12. doi: 10.1007/BF00230213. Hum Genet. 1993. PMID: 8454289 - Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization.
Matsumura K, Kallioniemi A, Kallioniemi O, Chen L, Smith HS, Pinkel D, Gray J, Waldman FM. Matsumura K, et al. Cancer Res. 1992 Jun 15;52(12):3474-7. Cancer Res. 1992. PMID: 1350754 - [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer].
Kashkin KN, Fleĭshman EV, Chumakov PM, Perevoshchikov AG. Kashkin KN, et al. Genetika. 1998 Aug;34(8):1049-55. Genetika. 1998. PMID: 9777351 Russian. - Molecular and cellular lesions associated with breast cancer progression.
Smith HS, Chen LC, Ngo JL, Ljung BM. Smith HS, et al. Breast Cancer Res Treat. 1991 May;18 Suppl 1:S51-4. doi: 10.1007/BF02633528. Breast Cancer Res Treat. 1991. PMID: 1873559 Review.
Cited by
- Overexpression of p53 protein in human tumors.
Inoue K, Kurabayashi A, Shuin T, Ohtsuki Y, Furihata M. Inoue K, et al. Med Mol Morphol. 2012 Jun;45(3):115-23. doi: 10.1007/s00795-012-0575-6. Epub 2012 Sep 22. Med Mol Morphol. 2012. PMID: 23001293 Review. - Cis lethal genetic interactions attenuate and alter p53 tumorigenesis.
Wang Y, Zhang W, Edelmann L, Kolodner RD, Kucherlapati R, Edelmann W. Wang Y, et al. Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5511-5. doi: 10.1073/pnas.1001223107. Epub 2010 Mar 8. Proc Natl Acad Sci U S A. 2010. PMID: 20212136 Free PMC article. - Genetic analysis of breast cancer progression.
Dairkee SH, Smith HS. Dairkee SH, et al. J Mammary Gland Biol Neoplasia. 1996 Apr;1(2):139-51. doi: 10.1007/BF02013638. J Mammary Gland Biol Neoplasia. 1996. PMID: 10887488 Review. - Identification of high-risk breast cancer patients from genetic changes of their tumors.
Watatani M, Inui H, Nagayama K, Imanishi Y, Nishimura K, Hashimoto Y, Yamauchi E, Hojo T, Kotsuma Y, Yamato M, Matsunami N, Yasutomi M. Watatani M, et al. Surg Today. 2000;30(6):516-22. doi: 10.1007/s005950070118. Surg Today. 2000. PMID: 10883462 - Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene.
Liscia DS, Morizio R, Venesio T, Palenzona C, Donadio M, Callahan R. Liscia DS, et al. Br J Cancer. 1999 May;80(5-6):821-6. doi: 10.1038/sj.bjc.6690427. Br J Cancer. 1999. PMID: 10360661 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical